This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Alveolar Rhabdomyosarcoma
Information about Alveolar Rhabdomyosarcoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Alveolar Rhabdomyosarcoma
Most recent studies have shown that Alveolar Rhabdomyosarcoma shares some biological mechanisms with bone-neoplasms, carcinoma, cell-transformation-neoplastic, chromosomal-translocation, ewings-sarcoma-primitive-neuroectodermal-tumor-(pnet), leukemia, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, neuroblastoma, neuroectodermal-tumors, rhabdomyosarcoma, rhabdomyosarcoma-embryonal, sarcoma, soft-tissue-neoplasms, synovial-sarcoma.
Among the many pathways, these few ones have gauged particular interests from scientists studying Alveolar Rhabdomyosarcoma, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Division, Cell Growth, Cell Migration, Cell Motility, Cell Proliferation, Coagulation, Dna Methylation, Interphase, Localization, Metaphase, Methylation, Oncogenesis, Pathogenesis, Reverse Transcription, Rna Interference
Quite a number of genes have been found to play important roles in Alveolar Rhabdomyosarcoma, such as ANXA2, DES, ERMAP, EWSR1, FOXO1, KIDINS220, MB, MYCN, MYOD1, MYOG, PAX3, PAX7, PEX7, PHYH, RHD, TP53, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.